Bookmark Add to Calendar

Stability Testing for Biological/Biotechnological Drug Substances and Drug Products

4408
Duration : 90 Minutes

Gwendolyn Wise-Blackman,

Gwen Wise-Blackman has 20 years of combined experience in Cell-Based Assays and Quality Systems. She has worked at DuPont Pharmaceuticals, Catalent Pharma Solutions (formerly Magellan Laboratories and Cardinal Health), Covance, and Salix Pharmaceuticals. Her focus has been in High-Throughput Screening, Cell-Based Assay Method De Read more


All drug substances and drug products require expiration dating. Data used to support and set expiry and shelf life must be collected and analyzed using guidelines set by regulatory agencies. Processes and considerations for small molecules are inadequate for large molecule therapeutics when planning for expiry dating. One issue to consider is that the complexity of large molecule therapeutics allows for a greater potential to lose potency through multiple pathways. This webinar addresses issues present when designing and implementing a stability program for large molecule therapeutics. Key topics will be addressed to provide insight into important issues that should be considered to assure maintenance of potency during shelf life of the product.

Course Objectives:

• Understanding the difference between stability for small molecules and large molecules or complex drug products
• Regulatory Expectations
• Special considerations for biologic stability
• Designing and validating stability indicating method
• Implementing a stability program
• Expiry dating

Background:

As with small molecule therapeutics, biologics require testing for stability. Documenting the stability of the biologic in different storage conditions is essential for setting specifications for expiry and shelf life. Understanding the possible pathways where degradation may occur is crucial to designing an appropriate stability program. Developing and validating stability indicating methods that assess possible pathways of degradation is important for the success of any stability program.

Why Should You Attend:

Biologics, as well as small molecule pharmaceutical products, require expiry dating. Data supporting expiry dating controls how long these products should remain on the shelf. To collect data that supports expiry dating drug substance and drug product must be thoroughly tested in stability indicating methods. Understanding the importance of these methods and the analysis and use of the data is necessary for personnel involved in product development, product testing, and product release.

Course Outline:

• Defining biologics
• Degradation pathways
• Areas of concern for loss of stability
• Setting strategy to control stability
• Testing CQAs
• Stability indicating methods
• Test conditions, including stress conditions
• Data requirements
• Considerations for expiry dating

What You Get:

•  Training Reference Materials
•  Live Q&A with our Expert
•  Participation Certificate
•  Access to Signup Community (Optional)
•  Reward Points

Who Will Benefit:

• Early Development and Product Design Personnel
• Process Design Personnel
• Quality Control Analyst
• Quality Assurance Personnel
• Lab Management
• Stability Personnel
• Manufacturing Personnel
• Shipping and Distribution Personnel
• Regulatory Affairs
• Drug Packaging Personnel

Please reach us at 1-888-844-8963 for any further assistance or if you wish to register

100% MONEY BACK GUARANTEED

Refund / Cancellation policy

Get In Touch

Subject : Stability Testing for Biological/Biotechnological Drug Substances and Drug Products


Similar Trainings

Total Organic Carbon Analysis for Cleaning Validation in Pharmaceutical Manufacturing
LIVE : Scheduled on 23-April-2024 :01:00 PM EDT
GMP Auditing of Facilities Performing Cell-Based Methods
LIVE : Scheduled on 31-May-2024 :01:00 PM EDT
paypal payment Comodo

Copyright ©2024 Signup Training. All rights reserved.